your market intelligence analyst
Search Results
217 results
Your search is now limited to «Eli Lilly» expert search.
Motley Fool 08/04/2020 18:27
The National Institutes of Health is starting a head-to-head trial of several antibody treatment candidates.
More from Motley Fool: 08/04/2020 04:42
To address the challenging aspects of running a clinical trial in a long-term care facility during a pandemic, Lilly created customized mobile research units to support the on-site study.
More from
CNBC - Business 08/03/2020 17:14
Eli Lilly is using mobile labs to study if its antibody drug can prevent Covid-19 in nursing homes.
More from CNBC - Business:
Investor's Business Daily 08/03/2020 09:10
Eli Lilly stock jumped early Monday after the drugmaker announced the start of Phase 3 testing to determine if one of its drugs can help prevent Covid-19 in nursing home residents and staff.
More from Investor's Business Daily:
CNBC - Market Insider 08/03/2020 07:49
Eli Lilly (LLY) – The drugmaker has begun a late-stage study to determine if an experimental Covid-19 antibody treatment can prevent the spread of the virus in nursing homes.
More from CNBC - Market Insider:
MarketWatch 08/03/2020 07:32
Shares of Eli Lilly & Co. gained 1.1% in premarket trading on Monday after the drugmaker said it started a Phase 3 trial for a treatment that aims to prevent COVID-19 infections in residents and workers in nursing homes. It is estimated that at least 8% of U.S. COVID-19 cases and more than 41% of deaths have occurred in people linked to nursing homes, according to The New York Times. Lilly is testing an experimental antibody it developed with the privately held AbCellera Biologics Inc. to see if it can prevent infections in people who live or work in a facility that has recently reported a case of the coronavirus. The antibody was identified in the blood sample of one of the first people in the U.S. to test positive for the virus. The trial.
More from MarketWatch:
Seeking Alpha 07/30/2020 19:10
Lilly and the broader pharmaceutical industry are working hard to develop new medicines to treat and to prevent the spread of COVID-19.
More from Seeking Alpha:
Pharmafile 07/30/2020 07:10
Lilly and Boehringer's Jardiance reduces hospitalisation and CV death risk from heart failure at Phase 3.
More from Pharmafile:
Updated Date: Thu, 30 Jul 2020 00:00:00 EDT.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
PR Newswire 07/28/2020 13:13
Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals Inc., a wholly owned subsidiary of Lilly, are studying P-tau217 as a biomarker of AD pathology.
More from PR Newswire:
GlobeNewswire 07/28/2020 02:00
Under the terms of the 2020 Amendment, Lilly will maintain the exclusive commercialization rights, and as a consequence, will continue to consolidate the sales of Elunate® in China.
More from GlobeNewswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications